Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Insulin signaling pathway | R-HSA-74752 | map04910 | valdecoxib | 119607 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | valdecoxib | 119607 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | valdecoxib | 119607 | drug-path |
| Pancreatic cancer | R-HSA-9700206 | map05212 | valdecoxib | 119607 | drug-path |
| Prostate cancer | R-HSA-2990872 | map05215 | valdecoxib | 119607 | drug-path |
| ErbB signaling pathway | R-HSA-168638 | map04012 | valdecoxib | 119607 | drug-path |
| Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | valdecoxib | 119607 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | valdecoxib | 119607 | drug-path |
| Vibrio cholerae infection | R-HSA-9609646 | map05110 | valdecoxib | 119607 | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | valdecoxib | 119607 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | valdecoxib | 119607 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | valdecoxib | 119607 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | crotamiton | 688020 | drug-path |
| Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | crotamiton | 688020 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | crotamiton | 688020 | drug-path |
| Tight junction | R-HSA-2134514 | map04530 | crotamiton | 688020 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | crotamiton | 688020 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | crotamiton | 688020 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | crotamiton | 688020 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | crotamiton | 688020 | drug-path |